Plasma level pharmacokinetics study of posaconazole with the sequential use of two oral formulations (oral suspension and solid tablets) in haematology patients with a high risk of invasive mycoses.

Trial Profile

Plasma level pharmacokinetics study of posaconazole with the sequential use of two oral formulations (oral suspension and solid tablets) in haematology patients with a high risk of invasive mycoses.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Apr 2016

At a glance

  • Drugs Posaconazole (Primary) ; Posaconazole
  • Indications Mycoses
  • Focus Pharmacokinetics
  • Most Recent Events

    • 27 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top